Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: povidone; hyprolose; maize starch; poloxamer; colloidal anhydrous silica; purified talc; magnesium stearate; glucose; titanium dioxide; propylene glycol; hypromellose - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms: upper respiratory tract infection: acute pharyngitis, tonsillitis, and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbation of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. non-gonococcal urethritis. children: roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis. acute tonsillitis. impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine an organisms susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - roxithromycin, quantity: 150 mg - tablet, film coated - excipient ingredients: povidone; hyprolose; maize starch; poloxamer; colloidal anhydrous silica; purified talc; magnesium stearate; glucose; titanium dioxide; propylene glycol; hypromellose - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms: upper respiratory tract infection: acute pharyngitis, tonsillitis, and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbation of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. non-gonococcal urethritis. children: roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis. acute tonsillitis. impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine an organisms susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - oxytetracycline dihydrate - oral tablet - 250mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - roxithromycin -

Canada - English - Health Canada

laboratoire riva inc. - doxycycline (doxycycline hyclate) - capsule - 100mg - doxycycline (doxycycline hyclate) 100mg - tetracyclines

Canada - English - Health Canada

laboratoire riva inc. - doxycycline (doxycycline hyclate) - tablet - 100mg - doxycycline (doxycycline hyclate) 100mg - tetracyclines

Canada - English - Health Canada

langford - oxytetracycline hydrochloride - liquid - 100mg - oxytetracycline hydrochloride 100mg - cattle; sheep; swine (pigs)

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cont_eth -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cont_eth -

Singapore - English - HSA (Health Sciences Authority)

beacons pharmaceuticals pte. ltd. - doxycycline hyclate 115mg equivalent to doxycycline - capsule - 100 mg - doxycycline hyclate 115mg equivalent to doxycycline 100mg